Pulmonary embolism: Difference between revisions

Jump to navigation Jump to search
Line 41: Line 41:


==Guidelines==
==Guidelines==
===ACC/AHA Guidelines===
[[Pulmonary embolism medical therapy#ACC/AHA 2011 Guidelines- Recommendations for Initial Anticoagulation for Acute PE (DO NOT EDIT)| Guidelines for Initial Anticoagulation for Acute PE]]
| [[Pulmonary embolism surgery#ACC/AHA 2011 Guidelines- Recommendations for Catheter Embolectomy and Fragmentation (DO NOT EDIT)|Surgical embolectomy]]
| [[Pulmonary_embolism_surgery#ACC/AHA 2011 Guidelines- Recommendations on IVC Filters in the Setting of Acute PE (DO NOT EDIT)|Inferior vena cava filters]]
| [[Pulmonary_embolism_surgery#ACC/AHA 2011 Guidelines-Recommendations for Endovascular Thrombolysis and Surgical Venous Thrombectomy (DO NOT EDIT)|Thromboreductive Strategies]]
| [[Pulmonary_embolism_surgery#ACC/AHA 2011 Guidelines- Recommendations for Percutaneous Transluminal Venous Angioplasty and Stenting (DO NOT EDIT)|Percutaneous Transluminal Venous Angioplasty and Stent Placement]]


===ESC Guidelines===
===ESC Guidelines===

Revision as of 16:03, 4 February 2013

Pulmonary Embolism Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Pulmonary Embolism from other Diseases

Epidemiology and Demographics

Risk Factors

Triggers

Natural History, Complications and Prognosis

Diagnosis

Diagnostic criteria

Assessment of Clinical Probability and Risk Scores

Pulmonary Embolism Assessment of Probability of Subsequent VTE and Risk Scores

History and Symptoms

Physical Examination

Laboratory Findings

Arterial Blood Gas Analysis

D-dimer

Biomarkers

Electrocardiogram

Chest X Ray

Ventilation/Perfusion Scan

Echocardiography

Compression Ultrasonography

CT

MRI

Treatment

Treatment approach

Medical Therapy

IVC Filter

Pulmonary Embolectomy

Pulmonary Thromboendarterectomy

Discharge Care and Long Term Treatment

Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Follow-Up

Support group

Special Scenario

Pregnancy

Cancer

Trials

Landmark Trials

Case Studies

Case #1

Pulmonary embolism On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Pulmonary embolism

CDC on Pulmonary embolism

Pulmonary embolism in the news

Blogs on Pulmonary embolism

Directions to Hospitals Treating Pulmonary embolism

Risk calculators and risk factors for Pulmonary embolism

For patient information, click here

Editor(s)-In-Chief: C. Michael Gibson, M.S., M.D. [1], The APEX Trial Investigators; Associate Editor(s)-in-Chief: Cafer Zorkun, M.D., Ph.D. [2]

Synonyms and keywords: PE; lung blood clot; blood clot-lung; embolism-pulmonary

Overview

Historical Perspective

Classification

Pathophysiology

Differentiating Pulmonary Embolism from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

Assessment of Pretest Probability | History and Symptoms | Physical Examination | Laboratory Findings | Arterial Blood Gas | D-dimer | Biomarkers | Electrocardiogram | Chest X Ray | Ventilation/Perfusion Scan | Echocardiography | Compression Ultrasonography | Chest CT | CT Pulmonary Angiography | MRI | Other Imaging Findings

Treatment

Treatment Approach

Medical Therapy

Surgery:

Catheter-Based Interventions | Surgical Embolectomy | Pulmonary Endarterectomy | Discharge Care

Discharge Care

Follow-Up/Recurrence | Support group

Special Scenarios

Pregnancy | Cancer

Landmark Trials

Guidelines

ESC Guidelines

Case Studies

Related Chapters


Template:WikiDoc Sources